10x Genomics Unveils Next-Generation In Situ Analysis Platform 'Atera' in Japan for the First Time; Symposium on June 18

10x Genomics (Japan entity: 10x Genomics Japan Co., Ltd.), a leading company in single-cell and spatial biology, has announced the next-generation platform for spatial in situ analysis, 'Atera'.

In recent years, the lack of high-quality biological data has become a major challenge in AI-driven drug discovery and biotechnology advancements. 'Atera' makes it possible to analyze the whole transcriptome of up to 800 samples per year at single-cell resolution while preserving the tissue environment. It turns 'large-scale, multi-dimensional spatial omics research,' previously considered technically and cost-prohibitive, into a reality, dramatically accelerating the pace of drug discovery and life science research.

Accordingly, as the first public unveiling of this product in Japan, a hybrid symposium 'World Tour Tokyo - Frontiers of Spatial Analysis Symposium' will be held on Thursday, June 18, 2026. The event will feature the first public display of a mock-up of the Atera instrument in Japan, along with presentations from leading Japanese researchers on the latest findings and clinical applications using the current system (Xenium).

⬛︎ The Next Frontier of Spatial Analysis: Features of Atera

Atera enables research at scales previously deemed 'impossible' through the following innovative features:

Unparalleled Scale: Enables analysis of up to 800 whole transcriptome samples per year, powerfully driving large-scale projects.

Uncompromising Spatial Analysis: Achieves the highest standards in performance, plex number, and throughput simultaneously.

Single-Cell Level Sensitivity: Provides spatial sensitivity equivalent to single-cell analysis, ensuring high data reliability.

⬛︎ Overview of '10x Genomics World Tour 2026'

Witness the next leap in spatial analysis, making the impossible possible.

Date & Time: Thursday, June 18, 2026, 13:00 - 17:00

Format: Hybrid (Tokyo venue and Zoom webinar)

Tokyo Venue: Bellesalle Onarimon Tower (with venue-only benefits)

Venue-Exclusive Benefits:

- First in-Japan demonstration of the next-generation 'Atera' and behind-the-scenes development stories
- In-person technical consultation with staff (experimental support desk)

Details and registration: (Pre-registration required)

⬛︎ Speakers (in no particular order)

- Dr. Yutaka Suzuki (Professor, Graduate School of Frontier Sciences, The University of Tokyo)
- Dr. Masashi Horie (Professor, Division of Molecular Pathology, Kobe University Graduate School of Medicine)
- Dr. Mitsuho Imai (Physician, TR Support Office, Department of Drug Development Promotion, National Cancer Center Hospital East)
- Dr. Keiichi Hatakeyama (Director, Division of Genome Analysis Research, Shizuoka Cancer Center Research Institute)
- Byron Hartman (Sr. Staff Product Manager, 10x Genomics)